Adapti (formerly Scepter Holdings) is a very early-stage company with two nascent business lines and no meaningful revenue. The first is Dermacia, a health and beauty product line sold online that has generated less than $15,000 in annual sales and has temporarily scaled back operations. The second is the Adapti platform, an AI-based tool that scrapes social media data and uses third-party AI models to match products with influencers, aiming to optimize advertising ROI. The platform cost roughly $500,000 to develop, was completed in 2024, and has run only a handful of transactions with no revenue. The company's strategy depends almost entirely on two pending acquisitions. The first is the Ballengee Group, a sports agency representing MLB and minor league baseball players, which the company expects to become its primary operating business. Post-acquisition, Adapti intends to use its platform to connect Ballengee athletes with brand sponsors, with management arguing that AI-driven automation makes it economically viable to serve lower-profile athletes who generate individually small revenues. The second pending deal is Matchpoint Connections, a software provider that helps universities manage Name, Image and Likeness arrangements for college athletes. Neither acquisition has closed, and there is no assurance either will. If both deals close, the intended business model would combine sports agency commissions, influencer marketing fees, and NIL software licensing.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →